Targeted Therapy Finder Advisors*

David Fisher MD PhD
David E Fisher MD PhD
Department of Dermatology
Harvard Medical School
Keith Flaherty MD
Keith T Flaherty MD
Department of
Medicine
Harvard Medical School

Learn the Science Behind the Targeted Therapy Finder

Science and the Melanoma Molecular Disease Model

RAF265

Summary

Name(s) Target Manufacturer Status
RAF265, CHIR-265 ARAF, BRAF, CRAF, VEGFR-2 Novartis In Phase 1 for malignant melanoma
#